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Objectives. This study was designed to determine the cliaieal 
value of a Doppier-derived index of combined systolic and dis- 
stolic myoeardial performance in the assessment of cardiac 
amyloidosis. 
Background. Cardiac amyloidosis is an infiltrative disease with 
diastolic and systolic dysfunction. Therefore, the index of myccar- 
dial performance combining systolic and diastolic time intervaIs 
could be a useful predictor of clinical outcome in cardiac amy- 
loidosis. 
Methods. The study included 45 patients with biopsy-proved 
amyloidosis and 45 age-matched normal subjects. Ah patients had 
typical echocardiographic features of amyloid cardiac involve- 
ment. A Doppler-derived index, defined as the sum of isovoiumet- 
rie contraction time and isovolumetric relaxation time divided by 
ejection time, was measured from left ventricular oufflow and 
mitral inflow Doppler velocity profiles recorded during routine 
e~~o~ardiography. The index as well as conventional systolic or 
diastolic e~kocardiographIc~~o~p~er variables were related to 
subsequent outcome, 
- . - 1 1 1 _  _ _ -  _ _ _ _  
-  
&s&. The isovoktmetric contraction and relaxation times 
were prolonged and ejection time was shortened (p < O.OOI) in 
patients with amyloidosis compared with that in normal subjects, 
resulting in a marked increase of the index from normaf vabtes 
(p c 0.001). In the amyloid group the index was highest in 
patients with a low stroke index or with both shortened mitt-at 
deceleration time and lower ejection fraction. by ueivariate 
analysis, New York Neart Association functional &ass, the index, 
ejection fraction and mitral deceleration time were significant 
predictors of outcome. However, by multivariate stepwise regres- 
sion analysis, functional class and the index were the oniy 
independent predictors of stirvivak 
Conclusions. The Doppler-derived index of combined systolic 
and diastolic myocardial performance correlates with global 
cardiac dysfunction and is a useftd predictor of clinical outcome 
in patients with cardiac amyloidosis. 
(9 Am CON Cwdioll996;28:458- 64) 
In amyloidasis the cause of death is most commonly due to 
cardiac involvement (l--4). The hallmark of cardiac involve- 
ment in amy:&dosis is the “stiff heart syndrome” (5,6), with 
relaxation abnormalities in the early stages and concurrent 
systolic dysfunction in advanced stages (7,g). Echocardiogra- 
phy is important in the diagnosis of cardiac involvement of 
amyloidosis (9-18). Severity and prognosis of cardiac amyloid- 
osis are assessed using wall thickness and different variables of 
systolic and diastolic function as measured by M-mode, two- 
dimensional and Doppler echocardiography (1,7,17). 
Cardiac dysfunction in cardiac amyloidosis has been de- 
scribed previously using systolic and diastolic time intervals of 
the left heart. Abnormalities of isovolumetric re!axation time 
or time constant (tau) have been demonstrated using M-mode 
(19) and Doppler echocardiography (20) or invasive manomet- 
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ric catheterization recordings (6,21). In addition, abnormalities 
of systolic time intervals in cardiac amyloidosis have been 
described using phonacardiographic and external carotid pulse 
tracing (22j. 
Intuitively, a measure of global cardiac performance com- 
bining systolic and diastolic time interva!s could therefore be a 
useful predictor of outcome in cardiac amyloidosis. More 
recently, an easily measured index of myclcardial performance, 
combining systolic and diastolic time intervals, was proposed 
(23). This index has been reported to be simple, reproducible 
and independent of heart rate and blood pressure and to 
correlate with severity of clinical congestive heart failure in 
patients with dilated cardiomyqathy (24). Conceptually, this 
index combines systolic and diastolic myocardial performance 
because it is defined as the sum of isovolumetric contraction 
time and isovolumetric relaxation time divided by ejection 
time. In the present study, we measured and compared this 
index in normal subjects and in patients wiih cardiac amy!oid- 
asis of variable severity. The purpose of this study was 1) to 
analyze how the Doppler index correlates with clinical and 
echocardiographic severity of cardiac dysfunction; and 2) to 
assess its incremental prognostic power in patients with cardiac 
amyloidosis. 
1 ,i 
Study patients. This was a retrospective study of 45 pa 
tients (29 men, 16 women; mean liSD] age 60 rt 10 years, 
range 42 to 76) with biopsy-proved amyloidosis and typical 
echocardiographic features of cardiac involvement, including 
refractoriness and thickening of myocdrdium, pericardial et& 
sion, thickening of interatrial septum and valvular tiss:le, as 
defined in previous studies (7-9,14,15). Patients coded as 
having excellent echocardiographic images typical of cardiac 
amyloidosis recorded between December 1989 and April 1995 
were selected from the Mayo Clinic echocardiography data 
base. The diagnosis was further established by the presence of 
amyloid at biopsy (boile ma.row, abdominal fat aspirate, 
rectal, liver or renal bQs$ in all patients. Fourteen patients 
also underwent cardiac biopsy to confirm cardiac involvement. 
Patients with atria1 fibrilhttion and atrioventricular (AV) block 
were excluded. Of 45 patients, primary amyloidosis was diag- 
nosed in 39 (33 lambda/6 kappa), familial amyloidcsis in 3 and 
senile amyloidosis in 3. At the time of the echocardiographic 
study, there was evidence of previous or concurrent congestive 
heart failure in 23 patients (51%). Twenty five patients (56%\ 
were in New York Heart Association functional class I or II, 
and 20 (44%) in class III or IV. Eight patients were taking 
digoxin (18%); 12 angiotensin-converting enzyme inhibitors 
(27%); 37 diuretic agents (S2%); 6 calcium blocking agents 
(13%); 1 beta-adrenergic blocking agent (2%); and 29 inter- 
mittent melphalan-prednisolone (64%). Follow-up data were 
obtained for each patient from the history charts, written 
correspondence or by phone. The mean duration of follow-up 
was 16.2 months. The cause of death was determined on the 
basis of hospital admission charts, death certificates or infor- 
mation from attending physicians. Forty-five age- and gender- 
matched normal subjects were selected from a previous study 
of Doppler echocardiography in healthy volunteers (25). All 
normal subjects had no symptoms suggestive of cardiovascular 
disease and physical examination? chest roentogenographic, 
electrocardiographic and two-dimensionaliDoppler echocar- 
diographic results were normal. 
Echocardiographic examination. Complete two-dimensional 
and Doppler echocardiograms were recorded as previously 
described using commercially available ultrasound instrumen- 
tation (26,27). A parasternal short-axis view at the midleft 
ventricular level was used for the following measraements: left 
ventricular end-systolic and end-diastolic dimensions, ventric- 
ular septal and left ventricular posterior wall thickness. Mean 
left ventricular wall thickness was measured as half of the sum 
of the septal and free wall thickness. Left ventricuiar ejection 
fraction was measured by the method of Quinones et al. (28). 
The mitral inflow velocity pattern was recorded from the apical 
four-chamber view with the pulsed wave Doppler sample 
vo!ume positioned at the tips of the mitral leaflets during 
diastole. The left ventricular outflow velocity pattern was 
recorded from the apical long-axis view with the pulsed wave 
DoppIer sample volume positioned just below the aortic valve. 
Dgure I. Schema for measurements of Dappler time intervals. Thz 
index is defined as (a - b)ib, where P is the interval between cessation 
and onset of the mitrzt inflow, and 6 is the ejection time (ET) of left 
ventricular (LV) outflow. Isovoiumetric relaxation time (IRT); is 
measured by subtracting the internal c between the R wave and the 
cessation of left ventricular outf!ow fram the intewal d between the R 
wave and the onset of mitral flow. Isovolumetric eomraction time 
(ICI’) is obtained by subtracting isovolumetric relaxation time from 
R - 5. ECG = echocardiogram; MCQ = inter;;1 from cessation to 
onset of mitral Row. 
Two-dimensional and Doppler tracings were recorded at a 
paper speed of 5tJ or 100 mm/s on O-75-in. videotape. 
Doppler measurements. Measurement of Doppler record- 
ings was carried out on an off-line commercial digitizing system 
(Freeland Systems analyzer). Five consecutive: betas were 
measured and averaged for each measurement. Doppler time 
intervafs were measured from mitral inflow and ieft ventricular 
outflow velocity time inter,lals (Fig. I). The interval II from the 
cessation to the onset of mitral inflow is equal to the sum of 
isovolumetric contraction time, ejection time and isovolumet- 
tic relaxation time. Left ventricular ejection ti;ne B is the 
duration of left ventricula outflow velociq profile. Thus, the 
sum of isovolumetric con:ra.ction time and isovolumetric relax- 
ation time was obtained b!: subtracting h from CZ. The index of 
combined left ventricular systolic 2nd diastolic function (the 
sum of isovolumetric contraction time and iso~~olumetric relax- 
ation time divided by ejection time) was calculated as (a - b):ib 
(23;). In addition, isovolumetric relaxation time was measured 
by subtractitrg th; irtterval iI between the Rwave and cessation 
of left ventricular outflow from the interval c between the R 
wave and the onset of mitral inflow (25). Isovolumetric can- 
traction time was calculated by subtracting the isovolumetric 
relaxation time from a -- b (Fig 1). Doppler measurements 
were made by independent observer (CT,) wi:h no knowledge 
of patient outcome. 
Statistical analysis. Continuous data are expressed as 
mean value ? SD and categoric data as percentages. Compar- 
isons of all measurements between normal su’?jects and pa- 
tients with cardiac amyloidosis; or comparison between two 
subgroups of cardiac amyloidosis defined by different grades of 
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Table 1. Glinical Profile and General Echocardiographici 
Doppler Findiilgs 
Patients With 
Normal Subjects Cardiac Anyiaidosis p 
(II = 45) (n = 45) Value 
Age (yr) 55 2 15 60 f 10 NS 
Maleikmale E/l6 29116 NS 
NYHA functional ciass 
Ii11 25 (%%) 
III/IV 20 (444 j 
History of CHF ZJ(S3Q) 
Heart rate (beatshin) 63 It 8 81 ?I 12 < 0.0001 
Systolic BP (mm Hg) 128 2 13 114 ir 21 c: 0.01 
Diastolic BP (mm Hg) 76 ‘- 8 12212 NS 
Ejection fraction (S) 62 14 SOI 15 c O.llGul 
LV wall thickness (mm) lOi! I6 ?I 3 c o.fEo1 
LVDd (mm) 4924 44 + 5 < 0.0001 
LAD (mm) 3625 44 2 6 -: O.o@O 1 
Mild MR 22 (49%) 
Moclerzte or severe MR 6 (13%) 
Mild i5 (33%) 
Modeiete or secere TR 5 (11%) 
__I_-- 
Data presented are mean value k SD or number (9&j) of patients. BP = 
blooc! pressure: CHF = congestive heart failure; LAD = left atria1 dimension; 
LV = left ventricular; LVDd = left ventricular end-diastolic dimension; MR = 
mitrai regurgitation: NYHA = New York Heart Association; TR = tricuspid 
regurgitation. 
New Y ark Heart Association functional class (I/II vs. III/IV), 
ejection fraction (60% vs. =-SO%), wall thickness (S-i5 vs. 
>15 mm), mitral deceleration time (~150 vs. >150 ms) and 
stroke index (~25 vs. ~25 mlimin per m’) were made using the 
unpaired t test. Values were considertd significantly differeat 
at p < 0.05. Survival free of cardiac death and overall survival 
were estimated in patients with cardiac amyloi&Sf, using the 
Kaplan-Meier method (29). The relation G s-,ecific factors to 
end points of interest were investigated both univariately and 
multivariately using the Cox proportional hazards model (30). 
‘The stepwise selection technique was used to construct the 
multivariate model. A 0.05 level of significance was applied to 
determine whether variables were added or removed from the 
model (30). 
Patient cfmactesistics. Clinical characteristics and general 
echocardiographic/Doppler !Wings are shown in Table 1. 
Mean left ventricular wall thickness, heart rate and left atria1 
dimension were significantly increased in patients with cardiac 
amyloidosis compared with those in normal subjects, whereas 
blood pressure and left ventricular dimension were signifi- 
cantly decreased, Mean ejection fraction was also iower in 
patients with cardiac amyloidosis, but ejection fraction was 
preserved (~-50%) in 24 (53%) of 45 patients, 
I)r;ppler measurements, Figure 2 shows an example of a 
measurement of the index in a normal subject and in a patient 
with cardiac amyloidosis. Both the isovolumetric contraction 
Figure 2. Pulsed wave Doppler echocardiograms of mitral inilow and 
left ventricular (Lv) outflow in a normal 38-year old male subject 
(ejection fraction 63%) and a 49-year old male patient with cardiac 
amyloidosis (ejection fraction 51%). The value of the index (a - b)/b is 
0.38 in the normal subject and 0.72 in the patient with cardiac amyloidosis. 
time and isovolumetric relaxation time were significantly pro- 
longed, whereas ejection time was significantly shortened in 
patients with cardiac amyloidosis compared with that in nor- 
mal subjects (Fig. 3). Thus, the index combining these variables 
was even more significantly different between cardiac amyloid- 
osis and normal sllbjects <Fig. 4). Table 2 summarizes the 
measurements of Doppler time intervals. Doppler-derived 
time intervals were significantly different between patients with 
cardiac amyloidosis and a mean ejection fraction <Xl% versus 
3~50%. However, these Doppler time intenals were not sig- 
nificantly different among patients with cardiac amyloidosis 
and a mean wall thickness 11.5 versus >I5 mm (Table 2). 
Comparison of Doppler index, The mean value of the 
index tended to be higher in patients in functional class III/IV 
than class I/II, with an ejection fraction 60% versus ~50% or 
mitral flow deceleration time ~153 versus >1.50 ms, but this 
finding did not reach statistical signific>na. However, there 
was a significant difference be&veer! patients $Y!Q 2: 0.11, n = 
15) with both ejection fraction <50% a& dederation time 
5150 ms and patients (0.73 f 0.15, n = 19) with both ejection 
fraction ~50% and deceleration time X50 ms (p < 0.01). In 
addition, the mean value of the index was significantly higher 
in patients (0.88 t 0.15, n = 21) with less than the median 
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Figure 3. Comparison of Doppler time intervals between normal 
subjects and patients with cardiac amyloidosis. Left ventricular iscI~~o!u- 
metric contraction time (XT) and isovolumetric relaxation time (!RT) 
were significantly prolonged, whereas left ventricular ejection time 
(ET) was significantly shortened in patients with cardiac amyloidosis 
compared with that in normal subjects. 
value of the stroke index (~2.5 mlimin per m”) than in patients 
(0.72 2 0.23, n = 20) with a stroke index ~25 n&in per rn’ 
(p < 0.01). 
Correlation of’ beart rate and ecb~a~d~o~a~b~~~opp~e~ 
variables. Table 3 shows the correlation between heart rate 
and echocardiogsaphic./Doppler variables in normal subjects 
and patients with cardiac amyloidosis. The interval n between 
cessation and onset of mitral inflow and the ejection time b 
were significantly related to neart rate in normal subjects as 
well as in patients with cardiac amyloidosis; however? the index 
(u - b)/b was independent of heart rate. 
Correlation of Mood pressure and e~ho~a~d~og~a~~E/ 
Doppler variables. All Doppler variables were unrelated to 
blood pressure in normal subjects, but there was a significant 
relation between systolic or diastolic blood pressure and 
intervals a and b and the isovolumetric relaxation time in 
patients wit‘h cardiac amyloidosis (Table 4), whereas the index 
was independent of systolic and diastolic blond pressures. 
Prognostic value af Doppler index. During a folio-w-up 
period of up to 3 years, 29 of 45 patients died (cardiac related 
in 23, noncatdiac related in 4, unknown in 2)‘ Of a!1 the 
Normal Amyloidosis 
Figure A Comparison of the index of combining systolic amI diastolic 
myocardial performance between oorma! subjects and patienfs with 
cardiac amyfoidosis. The index is significantlv prolonged 41 patients 
with cardiac amyloidosis compared wi!h lbat & normai subjects. 
echo~ardiographic~~oppler variables, the index was the best 
predictor of cardiac death by univariate analysis (Table 5). 
Multivariate stepwise regression analysis showed that func- 
tional class and index were the only independent predictors of 
cardiac death (Table 6), Figure 5 shows the survival curves 
based on the two subgroups with an index v&e either less than 
or greater than the median value of tbe index, indicating that 
the group with the higher value fM.77) had a worse outcome 
than the group with the lower value (~~0.77). Figure 5 shows 
that the index also predicted overall mortslity. 
Cardiac amyloidosis is characterized by varying degrees of 
systolic and diastolic dysfunctiran, which appear to have inde- 
pcndent prognostic value (7,17). Thus, a measure of combined 
systolic and diastolic myocardial performance could bz a useful 
predictor of outcome in these fyatients. Abnormalities of 
systolic and diastolic time intervals of the left heart cycle have 
been described in cardiac amyloidosis (6,211~22). However, 
there have been no previous studies in cardiac amyloidosis that 
have attempted to relate these intervals to other measurements 
of systolic and diastolic performance and clinical prognosis in 
cardiac amyloidosis. In the present study, the index of myocar- 
dial performanct‘ combining systolic and diastolic time inter- 
vals was compared with conventianal Doppler echocardio- 
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%abie 3. Correintion of Echocardio~rapiliciaoppler Variables 
With Heart Rate in Normal Subjects and Patients With 
Cardiac Amyloidosis --.-----___ - 
Table 4. Correlation of Echocardio~~phiciDoppier Variables With 
Blood Pressure in IPatients With Cardiac Amyloidosis -ll__----- _- 
Systolic Diastuiic 
Namnl Subjects 
-__- 
p Value 
Patients With 
Cardiac Amyloid& 
--ll_ll- 
r p VaIu2 
DT 0.25 
El‘4 0.X 
EF 0.10 
Dd 0.42 
ns 0.34 
SI 0.30 
CI 0.32 
MC0 (a) 0.42 
ET (ii) 0.3: 
IRT 0 17 
IST 0.32 
0.i6 NS 
G.13 NS 
0.26 c; il.05 
0.19 NS 
0.10 h’s 
0.13 NS 
0.30 i 0.05 
0.42 < 0.01 
0.48 < 0.0001 
0.22 NS 
t1.0 1 NS 
ICT+IRT 0.41 < 0.01 0.13 NS 
Ill&X 0.23 NS 0.17 NS 
Cl = cardiac index; Ds = end-systolic dimension; SI = stroka index: MC0 = 
in!erval from cessation to onset of mitral lloiv: other abbreviations as in Tables 
I and 2. 
graphic variables of left ventricular function and was related to 
clinical status and outcome of patients with cardiac amyloid- 
osis. 
Isovolum~tric contraction and relaxation times were pro- 
longed and ejection time ~85 shortened significantly in patients 
with amyloidosis compared with that in normal age-matched 
subjects. This caused a marked increase in the value of the 
index. All these intervals, except the index, demonstrated 
significant blood pressure or heart rate dependence. Thus, 
there was no need for normalization of the index. The index 
carreiated with global dysfunction and was significantly higher 
in the subgroup of patients with a lower stroke index, short- 
ened mitral deceleration time and lower ejectic:g &action. In 
the multivariate model, only functional class and index were 
independent predictors of clinical outcome. The index there- 
fore had significant prognostic power in addition to functional 
class, Univariately, both ejection fraction and deceleration 
time were predictors of outcome in this patient coho~i. How- 
ever, in the multivariate analysis they had no independent 
prognostic power. Tney did not add any prognostic informa- 
tion to that already conferred by functional class and the index. 
Use of the index may thus enhance the ability to plan mast- 
agement, especially if orthotopic cardiac transplantation is to 
be considered. 
Comparisun with previous work. The results of Doppler 
measurements of the individual time intervals are consistent 
with previous work in amyloid cardiomyopathy (6,20,22,31). A 
previous study demonstrated prolongation of isovolumetric 
relaxation time in early amyloidosis only, but the interval 
tended to be shortened in advanced stage with restrictive filling 
(20,31). In the present study, isovolumetric relaxation time was 
significantly prolonged, even in patients with advanced amy- 
lpidosis characterized by a meail left ventricular wall thickness 
D-l 0.26 c 0.0.5 
E/A 0.38 c 0.01 
EF $21: NS 
SI f?.39 c: 0.01 
Cl 0.23 NS 
MC0 {a) 0,47 < 0.0001 
ET (b) 0.47 c O.iWOl 
IRT 0.25 c 0.05 
ICI 0.09 KS 
ICT+IRT 0.23 NS 
Index 3.13 NS 
r p Value 
-.-- 
0.25 < 0.05 
11.33 < ii.05 
a.13 NS 
0.38 NS 
0.26 NS 
0.41 < 0.001 
0.3: < 0.05 
‘1.35 4 0.01 
0.09 NS 
0.29 < 0.05 
0.03 NS 
Abtrsviations as in Tables 1 to 3. 
r15 mm. This may be explained by the shortened ejection 
time, with earlier closure of the aortic valve. In addition, it has 
been shown by invasive manometry that the negative peak rate 
of left ventricular pressure increase (--dP/dt) is significantly 
abnormal in more advanced stages of cardiac amyloidosis (6). 
Left atria1 pressure increase causes earlier mitral valve open- 
ing, which tends to shorten isovolumetric time. Our results 
demonstrrrlc that the net result is prolongation of isovolumet- 
ric relaxation time, even in advanced cardiac amyloidosis. 
Prolongation of the preejection period previously observed 
in amyloid heart disease (22) is consistent with the prolonga- 
tion of isovolumetric contraction time observed in the present 
study. Even when ejection fraction is normal in early amyloid 
heart disease, isovohtmetric contraction time is prolonged. 
This suggests that some degree of systolic dysfunction may be 
present in early cardiac amyloidosis. The isovoiumetric con- 
traction time may be a more sensitive measure of systolic 
dysfunction than ejection fraction. 
Shortening of the ejection time has also been previously 
demonstrated (22). Elecause left ventricular end-diastolic vol- 
umes cannot increase in cardiac amyloidosis, shortening of the 
ejection time is associated with a decreased left ventricular 
stroke volume. This explains the higher value of the index in 
advanced amyloidosis, when the stroke volume starts to de- 
crease. 
Variable 
____I-. 
NYHA functional class 
Index 
Ejection fraction 
DT 
ICT 
Heart rate 
Wall thickness 
I3.4 
IRT 
Chi-Square 
12.4 
11.2 
6.9 
3.3 
3.9 
3.7 
0.6 
0.4 
0.2 
p Value 
<: O.Gui 
c: o.iP.lt 
0.009 
0.04 
G.!E 
0.05 
0.46 
0.51 
5.63 
Abbreviations as in Tables 2 to 3. 
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Taab?e 5. Multivariate Cox Regression Analysis Using Clinical and 
Echocardiographic Variahies -------~ 
Variable Chi-Squm p Value 
NEW3 functional class 7.4 0.OR7 
Index 4.6 0.032 ----l_l___---~---__I_ 
Abbreviations as in Tables 1 and 2. 
Several studies (7,17) have related two-dimensional and 
Doppler echocardiographic variables to outcome in cardiac 
amy!oidosis, In the present study, the univariate analysis 
conIirms the predictive value of functional class, ejection 
fraction and mitral decejeratiort time. However, wall thickness 
and mitral early/late diastolic peak velocity ratio did not have 
a significant predictive value in a univariate analysis. This may 
be due to selection bias, because the study included only a few 
patients with early cardiac involvement. 
Study limitations. interpretation of the individual time 
intervals is limited because of their dependency on loading 
conditions and heart rate. This problem was partially ad- 
dressed by demonstrating lack of correiation of the index with 
either heart rate or blood pressure (24). The inference of load 
dependency must ultimately be addressed in an experimental 
model. However, despite this possible limitation, the index 
provided relevant clinical information in patients with ad- 
vanced cardiac amyloidosis and appeared to be unaffected by 
heart rate or blood pressure. Moreover, other conventional 
echocardiographic variables, such as ejection fraction or decel- 
eration time, display significant load dependency, but this has 
not limited their clinical applicability. 
By design and selection, the majority of patients had 
advanced cardiac involvement. This may impiy that the ding- 
nosis of cardiac involvement w&s convincing and obviated the 
need for further scrutiny. However, the present study was 
primarily designed to show the value of the index in predicting 
outcome in this patient population. 
Patients with atria1 fibrillation and AV block were excluded 
Figure 5. Survival free of cardiac death in patients with cardiac 
amyloidosis. The group with an index greater than the median value 
(>0.77) has a higher mor~aIi!y risk than t&at with an index iowcr than 
the median value (z&77). Numbers in parentheses are number of 
patients. 
-----,r----- 
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215 3.0 
- fridex so.17 
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I .-..-a- 
0.0 0:s 1:o 
-----T‘------7 
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Years 
liigure 6. Overttill survival in patients with cardiac nn~ybitlosis. The 
group with an index greater than the median valoe (>0.77) has a 
higher mortality risk than th;tt with an in&s Iowcr than the median 
value (~0.77). The it&x predicts overa! marWy: regardless of cause 
of death. Numbers in parentheses are number of patients. 
from the study. This exclusion may limit extrapolation of this 
smvival analysis to all patients with cardiac amyloidosis. Ei- 
nally, the cause of death was based on clinical judgment. 
However, the index was related to overall survival, regardless 
of cause of death. 
Conclusions. A simple measure of Doppler index, combin- 
ing systolic and diastoIic time intervals as an expression of 
global myocardiai performance, correlates with overall cardiac 
function and seems to be a useful predictor ofc;inical outcome 
in patients with cardiac amyIoidosis. 
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